Pharmaceutical preparations for cardiovascular indications, for the treatment of inflammatory connective tissue diseases and injuries, for the treatment of cancer, the treatment of the central nervous system, namely, central nervous system infections, brain diseases and central nervous system movement disorders, and for the treatment of vasospasms associated with aneurysmal subarachnoid hemorrhage (aSAH)
REGISTERED
on 08 Apr 2021
PYFLAZ
IDORSIA PHARMACEUTICALS LTD.
1837196 · 11 May 2017
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for cardiovascular indications, for the treatment of inflammatory connective tissue diseases and injuries, for the treatment of cancer, the treatment of the central nervous system, namely, central nervous system infections, brain diseases and central nervous system movement disorders, and for the treatment of vasospasms associated with aneurysmal subarachnoid hemorrhage (aSAH)
Pharmaceutical preparations for cardiovascular indications, for the tr...
